| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/13/2008 | EP1885361A2 Acyl hydrazones for treating cardiovascular diseases |
| 02/13/2008 | EP1885359A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 02/13/2008 | EP1689748B1 Novel 8-(piperazine-1-yl)- and 8-( 1,4 diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 02/13/2008 | EP1517883B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1353938B1 Androgenic 7-substituted 11-halogenated steroids |
| 02/13/2008 | CN101120951A Ovarian moisturing soft capsule and preparing process thereof |
| 02/13/2008 | CN101120936A Application of chlorogenic acid in preparing medicine with estrogenic or estrogenic promoting action |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329750 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329669 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2294582C Treatment of diabetes with thiazolidinedione and metformin |
| 02/07/2008 | WO2008016768A1 Phytoestrogenic formulations and uses thereof |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008015226A1 Compositions and methods for treating diabetes and neuropsychological dysfunction |
| 02/07/2008 | WO2008015021A1 Treatment of endocrine dysfunction using iron chelators |
| 02/07/2008 | US20080033049 Hydroxy-Biphenyl-Carbaldehyde Oxime Derivatives and Their Use As Estrogenic Agents |
| 02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
| 02/07/2008 | US20080033011 Novel benzo[d][1,3]-dioxol derivatives |
| 02/07/2008 | US20080032959 Estrogen Receptor Modulators |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | DE102006038224A1 Procedure for the determination of neuroendocrinal health disorders such as e.g. chronic fatigue syndrome, comprises measuring glucocorticoids, sex steroids and amino acids/neurotransmitter and/or their metabolites in body fluids |
| 02/07/2008 | CA2659905A1 Phytoestrogenic formulations and uses thereof |
| 02/07/2008 | CA2659161A1 Treatment of endocrine dysfunction using iron chelators |
| 02/07/2008 | CA2657342A1 Atp-sensitive potassium channel ligand, selected from sulfamides and glinides, or any combination thereof and methods for treating diabetes and neuropsychological dysfunction |
| 02/06/2008 | EP1884244A1 Potassium channel ligands for treating diabetes and neuropsychological dysfunction |
| 02/06/2008 | EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 02/06/2008 | EP1883625A2 Amorphous cinacalcet hydrochloride and preparation thereof |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101119993A Aminophenyl derivatives as selective androgen receptor modulators |
| 02/06/2008 | CN101116666A Compositions of estrogen-cyclodextrin complexes |
| 02/06/2008 | CN100366295C Composition for intestinal delivery |
| 02/06/2008 | CN100366242C Non-dropped medicine releaser in vagina and its preparation and use |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326700 Prevention of prelabor during pregnancy; central nervous system disorders, psychological disorders |
| 02/05/2008 | US7326697 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/05/2008 | US7326688 Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes |
| 01/31/2008 | WO2007070450A3 Fast-acting oral peptide pharmaceutical products |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080026001 Pharmaceutical composition from natural materials for regulating immunity, its preparation method and use |
| 01/31/2008 | US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/30/2008 | EP1882684A1 Pyrrolidine derivative or salt thereof |
| 01/30/2008 | EP1881836A1 Method for preparing and using water-based steroid pheromone compositions |
| 01/30/2008 | EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | CN101112505A Chinese traditional medicine composition for treating breast hypertrophy disease |
| 01/30/2008 | CN100364612C Degraded agonist antibody |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/29/2008 | US7323454 Etonogestrel undecanoate, decanoate and/or dodecanoate; male and female contraception and hormone replacement therapy; endometriosis, menorrhagia, meno-metrorrhagia, pre-menstrual syndrome and dysmenorrhoea |
| 01/29/2008 | US7323165 Production of pancreatic islet cells and delivery of insulin |
| 01/29/2008 | CA2207078C Insulin derivatives with increased zinc binding |
| 01/24/2008 | WO2007136776A3 Pyrimidine low molecular weight ligands for modulating hormone receptors |
| 01/24/2008 | WO2006029371A3 Neuromedin u 2 receptor agonists and uses thereof |
| 01/24/2008 | US20080021231 Novel compounds |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021062 Alkylsulphonamide Quinolines |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021015 Use as medicine of a compound restoring active principles in vivo |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080021003 Extended step-down estrogen regimen |
| 01/24/2008 | US20080020971 Heptanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 01/24/2008 | US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/23/2008 | EP1881006A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 01/23/2008 | EP1879866A1 Dihydropyridine derivatives |
| 01/23/2008 | EP1879596A1 20-alkyl, gemini vitamin d3 compounds and methods of use thereof |
| 01/23/2008 | EP1879592A1 Use of inhibitors of steroid (testosterone) activity (i.a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 01/23/2008 | EP1879581A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| 01/23/2008 | EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111480A 取代的吡啶酮衍生物 Substituted pyridone derivative |
| 01/23/2008 | CN101111242A Tablets containing ornithine hydrochloride |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN100363377C N heterocyclic substituted adenosine derivatives |
| 01/22/2008 | US7321044 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320970 Low dose estrogen interrupted hormone replacement therapy |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320800 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |